Skip to main content
Rapid Dose Therapeutics Corp logo

Rapid Dose Therapeutics Corp — Investor Relations & Filings

Ticker · DOSE ISIN · CA75339A1012 CSE Manufacturing
Open in API
Filings indexed 490 across all filing types
Latest filing 2020-09-29 Regulatory Filings
Country CA Canada
Listing CSE DOSE

About Rapid Dose Therapeutics Corp

https://rapid-dose.com/

Rapid Dose Therapeutics Corp. is a pharma-technology company specializing in proprietary drug delivery technologies engineered to enhance patient outcomes and quality of life. The core business revolves around an innovative oral delivery platform utilizing sublingual thin film strip technology. The company's flagship product, QuickStrip™, is a fast-dissolving system designed for the rapid release of pharmaceuticals, micronized oils, and over-the-counter medicines. QuickStrip™ is distinguished by its ability to achieve blood concentrations comparable to intravenous injection, offering superior bioavailability and rapid onset. RDT provides product innovation, production, and consultation services to the pharmaceutical and healthcare manufacturing sectors for both prescription and non-prescription applications.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings
2020-09-29 English
News release - English.pdf
Board/Management Information Classification · 100% confidence The document announces the resignation of a board member, Mr. Henry Kloepper, from the company's board of directors. It is a clear announcement related to changes in the company's board of directors. The document is short and focused solely on this management change, with no financial data or other report content. Therefore, it fits the category of Board/Management Information (MANG).
2020-08-20 English
News release - English.pdf
Board/Management Information Classification · 100% confidence The document is a press release announcing the appointment of a new board member, Mr. Peter Thilo Hasler, to the board of directors of Rapid Dose Therapeutics Corp. It includes biographical details about the new board member and statements from the CEO. There is no financial data, no mention of financial results, no regulatory filings, no voting results, no merger or acquisition activity, and no other report types. The content clearly fits the category of announcements related to changes in the company's board of directors or senior management. Therefore, the appropriate classification is Board/Management Information (MANG). The document length is 4827 characters, which is consistent with a typical announcement rather than a full report.
2020-08-13 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing a credit facility financing arrangement by Rapid Dose Therapeutics Corp. It details the terms of the financing, including the amount, interest rate, use of funds, and warrants issued. There is no financial statement or comprehensive financial report included. The document is an update on the company's capital raising activities rather than a full financial report or earnings release. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is 5464 characters, which is sufficient for a detailed announcement but does not contain financial statements or analysis typical of interim or annual reports.
2020-08-11 English
News release - English.pdf
Regulatory Filings Classification · 100% confidence The document is a certification by the CEO of Boksburg Ventures Inc. regarding the interim financial report and interim MD&A for the period ended June 30, 2020. It is a Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate, which is a regulatory attestation about the accuracy and fair presentation of interim filings. The document does not contain actual financial statements or substantive financial data but is a certification letter. According to the Certification Rule, such officer certifications should be classified as Regulatory Filings (RNS) rather than as the interim report itself (IR). The document length is short (3543 characters), and it is clearly a certification, not the report or announcement of a report publication. Therefore, the correct classification is Regulatory Filings (RNS).
2020-08-01 English
News release - English.pdf
Regulatory Filings
2020-07-21 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.